India's CoviShield vaccine accepted by Europe, Switzerland, Iceland and seven EU nations namely Austria, Germany, Slovenia, Greece, Iceland, Ireland, Estonia and Spain for travel entry. Switzerland has also allowed a CoviShield for the state of Schengen.

The announcement comes a day after India requested the EU to accept covid-19 vaccines such as Covishield and Covaxin for Indian nationals travelling to Europe, Switzerland, Iceland and seven EU countries.

Slovenia, a country in Central Europe, said it would allow entry even to those who have received their first vaccine dose of Covishield, provided, "at least 21 days have passed since the first dose of the Covishield vaccine by the Serum Institute of India/AstraZeneca."

Austria states that a Covishield vaccination certificate is valid if one of the following conditions is met:

  1. 22 days, and not more than 3 months, have elapsed from 1 of 2 doses;
  2. have received the second dose of vaccine, and not more than 9 months have elapsed since the time of the first dose;
  3. 22 days, and not more than 9 months, have elapsed since vaccination in the case of vaccines, for which only one dose is prescribed.
According to diplomatic sources, Indian travellers who have been given the CoviShield vaccine can now get a green pass to enter Switzerland.

The Spanish authorities said that they would accept certificates of vaccination issued by the competent authorities or the medical service and mention, "The certificate of vaccination should be valid from 14 days after the date of administration of the last dose of the complete vaccination schedule."

"The vaccines authorized by the European Medicines Agency, as well as those that have completed the World Health Organisation’s emergency use process, are accepted. Currently, these vaccines are those produced by Pfizer-Biontech, Moderna, Astra-Zeneca, Jansen/Johnson&Johnson, Sinovac, and Sinopharm."

                ----------------------------------------------------------

Follow us for latest travel updates on FacebookTelegramLinkedIn and Twitter
                ----------------------------------------------------------

Post a Comment

Previous Post Next Post